Egypt Anti Aging Therapeutics Market Analysis

Egypt Anti-Aging Therapeutics Market Executive Summary

The Egypt anti-aging therapeutics market size is at around $2 Mn in 2022 and is projected to reach $6 Mn in 2030, exhibiting a CAGR of 18.03% during the forecast period. Following the budgets for public services, social protection, and education, the budget for healthcare investment is presently the fourth largest in Egypt's overall public budget. The report states that from FY20-21, healthcare services accounted for an average of 5.2% of total government expenditure, or 1.5% of GDP. A nearly 30% increase from the $850 Mn that was allocated for FY 2021–22, public investments in healthcare are scheduled at $1100 Mn for FY 2022–23. According to the report, Egypt's absence of a thorough regulatory system results in obstacles and drawn-out, challenging procedures that make entry into the private healthcare sector challenging. It is challenging for the private sector to get engaged in primary care due to requirements and regulations. For instance, only licensed doctors may own outpatient clinics.

The process of aging involves an individual going through gradual physiological changes. As a result of these modifications, typical biological processes are altered, including the capacity to handle metabolic stress, which ultimately results in cellular senescence. Genomic instability, telomere attrition, epigenetic changes, loss of proteostasis, nutrient sensing that is out of balance, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication are the nine markers of the process itself. These characteristics are risk factors for illnesses like cancer, cardiovascular disease, and neurodegenerative diseases.

Anti-aging therapeutics are the subject of some research studies being performed in Egypt. For instance, 2019 research in the journal "Aging and Disease" looked at how hesperidin affected mice's aging-related cognitive decline. Another investigation into the possible advantages of a vitamin and antioxidant combination for enhancing cognitive function in senior citizens was released in the "Journal of Clinical and Experimental Neuroimmunology" in 2020.

In the field of regenerative and anti-aging medicine, exosome therapy is a novel frontier. In recent years, it has drawn attention, and for the correct reasons. For those who prefer non-invasive anti-aging therapy, exosome therapy is especially intriguing. Exosomes are thought to function as a communication tool between cells, sending vital information that influences cellular processes like coagulation, elimination of waste, and regeneration. Exosomes are a crucial component of contemporary anti-aging treatment because of this property. Exosomes from various sources, including fat and stem cells, are used in exosome treatment to affect target cells. This treatment is employed to treat aging-related conditions, heal tissue, lessen inflammation, and control degenerative diseases. Target cells in the brain, blood, muscle, or epidermis are given instructions to regenerate and repair using exosomes. Exosomes accomplish this by adhering to and ingesting their target cells, which then receive the proteins and signals (signaling cytokines, mRNA, and miRNA) needed for cell regeneration and healing from the exosomes.

Market Dynamics

Market Growth Drivers Analysis

Egypt, like many other countries in the region, has a rapidly aging populace. In order to handle age-related health issues like wrinkles, fine lines, and age-related diseases, there is an increasing demand for anti-aging therapies and treatments. Egypt is becoming more and more conscious of the advantages of anti-aging therapies and procedures. As people age, they are more concerned with keeping their health and appearance and are looking for products and treatments that can assist them in doing so. Anti-aging technology and study have made significant strides in recent years. This has prompted the emergence of new, more potent medicines and treatments, which are now more widely accessible in Egypt.

Market Restraints

Egypt continues to experience economic instability due to high rates of unemployment and inflation despite recent economic development. This might make it more challenging for some consumers to purchase expensive anti-aging treatments due to their lower disposable income. The use of anti-aging therapies and treatments is not regulated in Egypt, which could result in the selling and consumption of harmful or ineffective products. This might reduce customer confidence and restrict Egypt anti-aging therapeutics market expansion. The market for anti-aging therapeutics is expanding in Egypt, but it is still relatively young, and many treatments might not be broadly accessible in all parts of the nation. The market's expansion may be constrained by this limited supply, especially in more rural regions.

Competitive Landscape

Key Players

• Apotec Bay (EGY)
• MTBI Diagnostics (EGY)
• MAS Scientific (EGY)
• Alpha Steel (EGY)
• CEB (EGY)
• Botogenix (EGY)
• Intervene Immune
• Khondrian
• Longeveron
• LyGenesis
• Mesoblast
• Minovia Therapeutics

Healthcare Policies and Regulatory Landscape

The Egyptian Drug Authority (EDA) is the organization in charge of regulating and monitoring the licensing of medications in Egypt, including anti-aging medications. The Ministry of Health and Population's EDA is in charge of ensuring that medications are secure, efficient, and of excellent quality. In Egypt, the EDA controls drug registration, importation, manufacturing, distribution, and promotion. The EDA must first assess a medication to make sure it satisfies the needed safety and efficacy requirements before approving it for use in Egypt. The EDA is also empowered to keep an eye on the quality and safety of medicines that are already on the market and to take appropriate action in the event that any problems are found. This might entail taking a drug off the market, levying penalties, or canceling a drug's license. Overall, the EDA is crucial in controlling the use of anti-aging medications in Egypt and ensuring that customers have access to secure and efficient treatments for age-related health issues.